What is Akari Therapeutics's free cash flow?

Akari Therapeutics had negative free cash flow of $10.57M in fiscal 2025 (fiscal year ended Mar 31, 2026).

Does Akari Therapeutics pay dividends or buy back shares?

Akari Therapeutics's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment.

Akari Therapeutics (AKTX) Cash Flow: Operating & Free Cash Flow

Akari Therapeutics Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Akari Therapeutics, Plc (AKTX) - Annual data in millions USD
Breakdown	FY 2025	FY 2025	FY 2024	FY 2024	FY 2023	FY 2023	FY 2022	FY 2022	FY 2021	FY 2021	FY 2020	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Mar 2026	Dec 2025	Mar 2025	Dec 2024	Mar 2024	Dec 2023	Mar 2023	Dec 2022	Mar 2022	Dec 2021	Mar 2021	Dec 2020	Mar 2020	Mar 2019	Dec 2017
Operating Activities
Net Income	-17.30	-31.34	-19.79	-20.84	-10.01	-12.83	-17.75	-13.09	-17.42	-20.49	-17.08	-17.08	-16.85	-23.50	-35.40
Depreciation & Amortization	0.00	-	0.01	0.01	0.00	0.31	0.00	0.79	0.00	0.00	0.01	0.01	0.02	0.04	0.04
Deferred Income Tax	-1.09	-1.09	0.00	-	0.00	-	0.00	-	0.00	-	0.00	-	0.00	0.00	-2.49
Stock Based Compensation	2.89	2.89	2.25	2.25	1.15	1.15	0.74	0.74	0.31	0.31	0.33	0.33	1.05	1.65	2.73
Change in Working Capital	-0.40	-0.40	6.54	6.54	-0.87	-0.87	0.82	0.82	-1.98	-1.98	-0.06	-0.06	3.09	-0.62	0.81
Change in Accounts Receivable	0.00	0.59	0.00	1.32	0.00	-	0.00	-	0.00	-1.74	0.00	-	0.00	0.00	0.00
Change in Accounts Payable	0.00	-1.33	0.00	5.76	0.00	3.84	0.00	2.59	-0.24	-0.24	0.00	-0.25	0.00	-3.69	0.01
Change in Other Working Capital	-0.40	-2.37	6.54	1.28	-0.87	-0.18	0.82	-0.22	-1.74	3.07	-0.06	0.19	3.09	3.07	0.80
Other Operating Activities	5.33	-2.37	-1.56	-1.89	-6.71	3.82	-5.32	1.89	0.24	0.24	-0.15	-0.15	-0.23	-0.11	2.70
Net Cash from Operating Activities	-10.57	-10.57	-12.55	-12.55	-16.43	-16.43	-21.50	-21.50	-18.85	-18.85	-16.95	-16.95	-12.92	-22.54	-31.60
Investing Activities
Capital Expenditures	0.00	-	0.00	-	0.00	-	0.00	-0.14	0.00	-	0.00	-	0.00	0.00	-0.04
Acquisitions	0.00	-	0.38	0.38	0.00	-	0.00	-	0.00	-	0.00	-	0.00	0.00	0.00
Sales/Maturities of Investments	0.00	-	0.00	-	0.00	-	0.00	-	0.00	-	0.00	-	0.00	0.00	10.02
Other Investing Activities	0.00	-	0.00	0.38	0.00	-	0.00	-	0.00	-	0.00	-	0.00	0.00	0.01
Net Cash from Investing Activities	0.00	-	0.38	0.38	0.00	-	0.00	-0.14	0.00	-	0.00	-	0.00	0.00	9.99
Financing Activities
Debt Repayment	1.05	-1.05	-0.86	-0.75	0.00	-0.30	0.00	-	0.00	-	0.00	-	0.00	0.00	0.00
Common Stock Issued	12.12	10.73	11.82	12.78	7.02	1.14	25.19	6.43	14.29	14.45	25.05	25.07	12.65	0.50	15.67
Other Financing Activities	0.00	1.37	0.03	-1.28	0.00	-	0.09	0.11	0.00	-0.16	0.03	-	0.00	-0.19	0.00
Net Cash from Financing Activities	13.17	13.17	10.99	10.99	7.02	7.02	25.29	25.29	14.29	14.29	25.07	25.07	12.65	0.31	15.67
Summary
Effect of Forex Changes on Cash	0.00	0.00	0.00	0.00	0.01	0.02	0.11	-0.06	-0.14	-0.14	0.20	-	0.03	-0.05	-0.05
Net Change in Cash	2.60	2.60	-1.19	-1.19	-9.41	-9.41	3.89	3.89	-4.69	-4.69	8.32	8.32	-0.24	-22.28	-5.99
Cash at Beginning of Period	2.66	2.66	3.85	3.85	13.25	13.25	9.36	9.36	14.06	14.06	5.73	-	5.97	28.25	34.10
Cash at End of Period	5.26	5.26	2.66	2.66	3.85	3.85	13.25	13.25	9.36	9.36	14.06	-	5.73	5.97	28.11
Free Cash Flow	-10.57	-10.57	-12.55	-12.55	-16.43	-16.43	-21.50	-21.50	-18.85	-18.85	-16.95	-16.95	-12.92	-22.54	-31.64

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Akari Therapeutics (AKTX) Cash Flow Statement

Akari Therapeutics Cash Flow Statement Analysis

Frequently Asked Questions About Akari Therapeutics Cash Flow